Study unravels a cause of resistance to novel drug in patients with acute leukemia
A new targeted drug has not only sparked remissions in patients with a common form of leukemia but also induced the cancer cells to reveal one of their schemes for resisting the drug, investigators report in a new pair of studies.
Materials provided by Dana-Farber Cancer Institute. Note: Content may be edited for style and length.
Source link aaaaa